Meta-analysis of pre-operative magnetic resonance imaging (MRI) and surgical treatment for breast cancer
- 1k Downloads
Although there is no consensus on whether pre-operative MRI in women with breast cancer (BC) benefits surgical treatment, MRI continues to be used pre-operatively in practice. This meta-analysis examines the association between pre-operative MRI and surgical outcomes in BC.
A systematic review was performed to identify studies reporting quantitative data on pre-operative MRI and surgical outcomes (without restriction by type of surgery received or type of BC) and using a controlled design. Random-effects logistic regression calculated the pooled odds ratio (OR) for each surgical outcome (MRI vs. no-MRI groups), and estimated ORs stratified by study-level age. Subgroup analysis was performed for invasive lobular cancer (ILC).
Nineteen studies met eligibility criteria: 3 RCTs and 16 comparative studies that included newly diagnosed BC of any type except for three studies restricted to ILC. Primary analysis (85,975 subjects) showed that pre-operative MRI was associated with increased odds of receiving mastectomy [OR 1.39 (1.23, 1.57); p < 0.001]; similar findings were shown in analyses stratified by study-level median age. Secondary analyses did not find statistical evidence of an effect of MRI on the rates of re-excision, re-operation, or positive margins; however, MRI was significantly associated with increased odds of receiving contralateral prophylactic mastectomy [OR 1.91 (1.25, 2.91); p = 0.003]. Subgroup analysis for ILC did not find any association between MRI and the odds of receiving mastectomy [OR 1.00 (0.75, 1.33); p = 0.988] or the odds of re-excision [OR 0.65 (0.35, 1.24); p = 0.192].
Pre-operative MRI is associated with increased odds of receiving ipsilateral mastectomy and contralateral prophylactic mastectomy as surgical treatment in newly diagnosed BC patients.
KeywordsBreast cancer Breast-conserving surgery Magnetic resonance imaging Mastectomy Meta-analysis Re-operation
NH receives funding via a National Breast Cancer Foundation (Australia) Breast Cancer Research Leadership Fellowship.
Compliance with ethical standards
Conflict of interest
All authors declare that they have no conflict of interest.
- 7.Solin LJ, Orel SG, Hwang WT, Harris EE, Schnall MD (2008) Relationship of breast magnetic resonance imaging to outcome after breast-conservation treatment with radiation for women with early-stage invasive breast carcinoma or ductal carcinoma in situ. J Clin Oncol 26:386–391CrossRefPubMedGoogle Scholar
- 11.Brennan ME, Houssami N, Lord S et al (2009) Magnetic resonance imaging screening of the contralateral breast in women with newly diagnosed breast cancer: systematic review and meta-analysis of incremental cancer detection and impact on surgical management. J Clin Oncol 27:5640–5649CrossRefPubMedGoogle Scholar
- 19.American College of Radiology (ACR). ACR practice guideline for the performance of contrast-enhanced magnetic resonance imaging (MRI) of the breast. 2008Google Scholar
- 33.(33) McGhan LJ, Wasif N, Gray RJ et al. Use of preoperative magnetic resonance imaging for invasive lobular cancer: good, better, but maybe not the best? Annals of Surgical Oncology 2010;17:Suppl-62Google Scholar
- 39.Vapiwala N, Hwang WT, Kushner CJ, Schnall MD, Freedman GM, Solin LJ (2017) No impact of breast magnetic resonance imaging on 15-year outcomes in patients with ductal carcinoma in situ or early-stage invasive breast cancer managed with breast conservation therapy. Cancer 123:1324–1332CrossRefPubMedGoogle Scholar
- 42.Morrow, Abrahamse P, Hofer TP, Ward KC, et al (2017) Trends in reoperation after initial lumpectomy for breast cancer: addressing overtreatment in surgical management. Ann Surg Oncol (in press)Google Scholar
- 46.Saini V, Garcia-Armesto S, Klemperer D et al (2017) Drivers of poor medical care. Lancet 06:2017Google Scholar
- 47.Brownlee S, Chalkidou K, Doust J et al (2017) Evidence for overuse of medical services around the world. LancetGoogle Scholar